Epiomed Therapeutics' Series B Round

Epiomed Therapeutics raised a round of funding on May 01, 2013. Investors include NDI Capital.

Epiomed Therapeutics is a development stage pharmaceutical organization focused on the discovery, development and partnering of anti-emetic (anti-vomiting and anti-nausea) compounds for both the human…

Articles about Epiomed Therapeutics' Series B Round: